Showing results (191-200 of 211) with videos related to
Sort By:
Pageof 22
Molecular Cancer Therapeutics|August 19, 2010
From NPC therapeutic target identification to potential treatment strategyMing-Ying Lan, Chi-Long Chen, Kuan-Ting Lin, et al.Molecular & Cellular Proteomics : MCP|March 21, 2008
Alternative splicing in colon, bladder, and prostate cancer identified by exon array analysisKasper Thorsen, Karina D Sørensen, Anne Sofie Brems-Eskildsen, et al.Cell|August 16, 2015
CRISPR Inversion of CTCF Sites Alters Genome Topology and Enhancer/Promoter FunctionYa Guo, Quan Xu, Daniele Canzio, et al.Journal of Cellular and Molecular Medicine|October 23, 2019
In silico identification of thiostrepton as an inhibitor of cancer stem cell growth and an enhancer for chemotherapy in non-small-cell lung cancerTse-Hung Huang, Alexander T H Wu, Tai-Shan Cheng, et al.Leukemia|February 14, 2020
SRSF1 mediates cytokine-induced impaired imatinib sensitivity in chronic myeloid leukemiaJoanna R Sinnakannu, Kian Leong Lee, Shanshan Cheng, et al.Oncotarget|March 13, 2015
Gluconeogenesis, lipogenesis, and HBV replication are commonly regulated by PGC-1α-dependent pathwayHong-Jhih Jhuang, Wei-Hsiang Hsu, Kuan-Ting Lin, et al.ACS Sustainable Chemistry & Engineering|August 8, 2025
Storage-Induced Collapse of Lignin Macromolecular Structure and Its Impacts on the BiorefineryYining Zeng, Kuan-Ting Lin, Renee M Happs, et al.Science (New York, N.Y.)|December 20, 2014
RNA splicing. The human splicing code reveals new insights into the genetic determinants of diseaseHui Y Xiong, Babak Alipanahi, Leo J Lee, et al.Plos One|November 17, 2011
Gene expression-based chemical genomics identifies potential therapeutic drugs in hepatocellular carcinomaMing-Huang Chen, Wu-Lung R Yang, Kuan-Ting Lin, et al.Genes & Cancer|February 7, 2024
Mechanistically based blood proteomic markers in the TGF-β pathway stratify risk of hepatocellular cancer in patients with cirrhosisXiyan Xiang, Krishanu Bhowmick, Kirti Shetty, et al.Pageof 22